Brokers name 3 ASX shares to buy right now 24 December 2020

Australia’s top brokers have been busy adjusting their estimates and recommendations again, leading to the release of a large number of broker notes this week.

Three broker buy ratings that have caught my eye are summarised below. Here’s why brokers think these ASX shares are in the buy zone:

According to a note out of Morgans, its analysts have initiated coverage on this medical device company’s shares with an add rating and $1.42 price target. The broker notes that the company’s NeuroNode technology allows severely disabled people to operate and communicate via a computer using visual and neural signals. It appears positive on its long term future and notes that it is targeting a market worth $1.2 billion a year. The…